Filtros de búsqueda

Lista de obras de David A. Lipson

(3)He pO2 mapping is limited by delayed-ventilation and diffusion in chronic obstructive pulmonary disease

scientific article published on 01 March 2014

24-Hour Serial Spirometric Assessment of Once-Daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULFIL Study

scientific article published on 03 October 2020

A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome.

artículo científico publicado en 2015

A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation

artículo científico publicado en 2012

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol

artículo científico publicado en 2016

A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome

artículo científico publicado en 2017

A small animal model of regional alveolar ventilation using HP 3He MRI1.

artículo científico publicado en 2004

Alternatives to lung transplantation: lung volume reduction surgery and continuous intravenous prostacyclin.

artículo científico publicado en 2002

An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease.

artículo científico publicado en 2011

Apical Perfusion Fraction as a Predictor of Short-term Functional Outcome Following Bilateral Lung Volume Reduction Surgery

scientific article published on 01 November 2001

Autoantibodies to variable heavy (VH) chain Ig sequences in humans impact the safety and clinical pharmacology of a VH domain antibody antagonist of TNF-α receptor 1.

artículo científico publicado en 2013

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

scientific article published on 04 July 2019

Bronchoscopy for atelectasis in the ICU: a case report and review of the literature.

artículo científico publicado en 2003

CORRELATION OF THE MULTIPLE INERT GAS ELIMINATION TECHNIQUE WITH VENTILATION/PERFUSION SCANNING USING NON-RADIOACTIVE HYPERPOLARIZED 3HE AND ARTERIAL SPIN TAGGING MRI

Co-registration of acquired MR ventilation and perfusion images--validation in a porcine model.

artículo científico publicado en 2003

Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study.

artículo científico publicado en 2017

Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation

scientific article published on 01 June 1998

Detection of simulated pulmonary embolism in a porcine model using hyperpolarized 3He MRI

scientific article published on 01 February 2004

Determination of regional VA/Q by hyperpolarized 3He MRI.

artículo científico publicado en 2004

Direct visualisation of collateral ventilation in COPD with hyperpolarised gas MRI

scientific article published on 27 January 2012

Dynamic observation of pulmonary perfusion using continuous arterial spin-labeling in a pig model

scientific article published on 01 August 2001

Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

artículo científico publicado en 2020

Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of the IMPACT Trial

scientific article published on 05 October 2020

Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised study

artículo científico publicado en 2018

Efficacy and Safety of Once-Daily Inhaled Umeclidinium in Asian Patients with COPD: Results from a Randomized, Placebo-Controlled Study

scientific article published on 17 April 2020

Efficacy and safety of the dual bronchodilator combination umeclidinium/vilanterol in COPD by age and airflow limitation severity: A pooled post hoc analysis of seven clinical trials

artículo científico publicado en 2019

Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT

artículo científico publicado en 2020

Efficacy of Umeclidinium/Vilanterol in Elderly Patients with COPD: A Pooled Analysis of Randomized Controlled Trials

artículo científico publicado en 2018

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial

scientific article published on 30 October 2019

FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease

artículo científico publicado en 2017

Giant gastric ulcers and risk factors for gastroduodenal mucosal disease in orthotopic lung transplant patients.

artículo científico publicado en 1998

Hyperpolarized 13C MRI of the pulmonary vasculature and parenchyma.

artículo científico publicado en 2007

Hyperpolarized helium-3 MR imaging of pulmonary function

artículo científico publicado en 2005

Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial

artículo científico publicado en 2020

Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis

artículo científico publicado en 2019

InforMing the PAthway of COPD Treatment Single-Inhaler Triple Therapy (Fluticasone Furoate/ Umeclidinium/ Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium /Vilanterol in Patients With COPD: Analysis of the Western Europe and North

artículo científico publicado en 2020

Measurements of regional alveolar oxygen pressure using hyperpolarized 3He MRI.

artículo científico publicado en 2005

Measuring disease activity in COPD: is clinically important deterioration the answer?

artículo científico publicado en 2020

Misinterpretation of time-to-first event curves can lead to inappropriate treatment

scientific article published on 05 September 2019

Multiple regression method for pulmonary apparent diffusion coefficient measurement by hyperpolarized 3He MRI.

artículo científico publicado en 2007

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.

artículo científico publicado en 2018

Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial

artículo científico publicado en 2017

Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life.

artículo científico publicado en 2018

Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials

artículo científico publicado en 2020

One More Time: The Impact of ICS Withdrawal on IMPACT

artículo científico publicado en 2020

Operating characteristics of hyperpolarized 3He and arterial spin tagging in MR imaging of ventilation and perfusion in healthy subjects

artículo científico publicado en 2003

PNEUMOTHORAX DETECTED BY NOVEL MRI VENTILATION/PERFUSION SCANNING USING NON-RADIOACTIVE HYPERPOLARIZED 3HE AND ARTERIAL SPIN-TAGGING

Perfusion scintigraphy and patient selection for lung volume reduction surgery

artículo científico publicado en 2010

Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

artículo científico publicado en 2020

Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD

scientific article published on 15 May 2018

Post-mortem stability of thyrotropin-releasing hormone and muscarinic cholinergic receptors in rat forebrain

scientific article published on 01 January 1989

Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β-Agonist Therapy: An Integrated Post Hoc Analysis

article

Preventing clinically important deterioration with single-inhaler triple therapy in COPD

article published in 2018

Pulmonary ventilation and perfusion scanning using hyperpolarized helium-3 MRI and arterial spin tagging in healthy normal subjects and in pulmonary embolism and orthotopic lung transplant patients

scientific article published on 01 June 2002

Redefining treatment in COPD: new directions in bronchodilator therapy.

artículo científico publicado en 2004

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients

scientific article published on 12 March 2020

Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipient.

artículo científico publicado en 2005

Reply to: "Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies"

artículo científico publicado en 2020

Reply to: Increased Propensity for Pneumonia with Fluticasone in COPD.

artículo científico publicado en 2017

Reply to: Letter Regarding the FULFIL Trial

artículo científico publicado en 2017

Reply to: Mortality in IMPACT: Confounded by Asthma?

scientific article published on 12 May 2020

Reply to: The Role of Eosinophil During the Withdrawal of Inhaled Corticosteroid in COPD

artículo científico publicado en 2020

Reply: "FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease" and "Triple Therapy in Chronic Obstructive Pulmonary Disease"

artículo científico publicado en 2017

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

artículo científico publicado en 2006

Risk of Exacerbation and Pneumonia with Single Inhaler Triple Versus Dual Therapy in IMPACT

artículo científico publicado en 2020

Single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the China cohort in the IMPACT trial

scientific article published on 30 October 2020

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study

artículo científico publicado en 2020

Single-Inhaler Triple versus Dual Therapy in Patients with COPD

scientific article published on 01 August 2018

Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study

artículo científico publicado en 2018

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial

artículo científico publicado en 2020

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses.

artículo científico publicado en 2018

Tension pneumoperitoneum associated with a pleural-peritoneal shunt

scientific article published on 01 September 1999

The Effect of Exacerbation History on Outcomes in the IMPACT Trial

artículo científico publicado en 2020

The Effect of ICS Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study: A Randomized, Double-blind Multicenter Trial

artículo científico publicado en 2020

The Efficacy and Safety of Once-daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-daily Budesonide/Formoterol in a Subgroup of Patients from China with Symptomatic COPD at Risk of Exacerbations (FULFIL Trial)

scientific article published on 01 June 2018

The IMPACT Study - Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI And UMEC/VI In Patients With COPD: Efficacy And Safety In A Japanese Population

artículo científico publicado en 2019

The adenosine 2A receptor agonist GW328267C improves lung function after acute lung injury in rats.

artículo científico publicado en 2012

Tiotropium bromide

scientific article published on 01 January 2006

Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial

artículo científico publicado en 2020

Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis

scientific article published on 20 June 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda